Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Pain. 2021 Mar 1;162(3):976–985. doi: 10.1097/j.pain.0000000000002095

Table 4.

Child Pain and Analgesic Outcomes in the Groups (tallied from daily diaries and surveys)

Control n=292 STOMP n=271 Odds Ratio or Mean Difference [95% CI]
Opioid given at home (yes vs. no) 240 (81.1%) 216 (79.1%) 0.88 [0.59, 1.34]
Opioid doses dispensed 21.5 ± 13.76 22.0 ± 16.48 0.50 [−1.95, 2.96]
Opioid doses given at home (total) 7.9 ± 8.6 8.6 ± 10.3 0.71 [−0.87, 2.28
Opioid meq/kg given 0.20 ± 0.23 0.21 ± 0.26 0.01, [−0.33, 0.05]
Days opioid given 3.31 ± 3.2 3.80 ± 4.2 0.49 [−0.13, 1.12]
OTC doses given 20.2 ± 16.0 19.7 ± 15.3 −0.45 [−3.06, 2.16]
Days OTC given 7.6 ± 4.6 7.8 ± 5.2 0.18 [−0.63, 1.00]
Child self-reported pain scores
 Days 1 to 3 4.9 ± 2.0 4.9 ± 2.0 [−0.36, 0.33]
 Days 4 to 7 3.8 ± 1.8 4.0 ± 2.1 0.16 [−0.23, 0.54]
 Days 8 to14 3.2 ± 1.9 3.5 ± 2.3 0.30 [−0.23, 0.83]
Parent-reported Pain Interference Score Day 14 8.06 ± 8.06 8.63 ± 8.39 0.57 [−0.68, 1.82]
Adverse events (yes vs. no)
 Nausea (requiring intervention) 34 (14.2%) 23 (9.9%) 0.66 [0.38, 1.17]
 Constipation (requiring intervention) 105 (46.3%) 106 (47.5%) 1.05 [0.73, 1.52]
 Moderate to severe sedation 45 (19.1%) 37 (15.9%) 0.80 [0.49, 1.29]
 Serious adverse events* 10 (3.4%) 9 (3.3%) 0.93 [0.37, 2.33]

Data shown as n (%) or mean ± standard deviation. Univariate comparisons were made using Chi-square or unpaired t-tests. Unadjusted odds ratios are shown.

Meq/kg=Morphine equivalents per kilogram; OTC=Over-the-counter;

*

serious adverse events include those that led to a call or unplanned return visit to the clinic or hospital setting as determined by medical record review. Other adverse effects were reported by parents on their daily diaries; percentages were calculated from those who reported events.